Aigerim Sagymbayeva

Dr. Aigerim Sagymbayeva

Research Institute for Biological Safety Problems, Almaty, Kazakhstan
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
NANurika Narynbekovna Assanzhanova
Nurika Narynbekovna Assanzhanova
Kuandyk ZhugunissovKuandyk Zhugunissov
Kuandyk Zhugunissov
OCOlga Chervyakova
Olga Chervyakova
SRSholpan Ryskeldinova
Sholpan Ryskeldinova
Nurlan AkmyrzayevNurlan Akmyrzayev
Nurlan Akmyrzayev
AMAigerim Mailybayeva
Aigerim Mailybayeva
Brucellosis remains one of the most widespread zoonotic infections worldwide, causing serious veterinary, medical, and socio-economic consequences. The disease, caused by bacteria of the genus Brucella, affects a wide range of domestic and wild animals as well as humans, with global incidence potentially reaching 1.6–2.1 million new cases annually. The most effective approach to combating brucellosis is specific prevention through vaccination. Therefore, we conducted this review to summarize data from existing studies on modern strategies for brucellosis vaccination, types of vaccine platforms, their efficacy, safety, and applicability in veterinary and human medicine. We searched databases including PubMed, Scopus, and Web of Science to identify relevant scientific articles in English published from 1990 to 2025. The aim of this work is to conduct a systematic analysis of modern brucellosis vaccination strategies in livestock and humans, as well as to evaluate the prospects of new vaccine platforms. The review examines live attenuated, inactivated, subunit, vector, and DNA vaccines, as well as their immunological mechanisms of action, advantages, and limitations of application. This information allows for a better understanding of the mechanisms of protective immunity formation and challenges related to DIVA diagnostics (Differentiating Infected from Vaccinated Animals). The “One Health” concept demonstrated the interconnection between human, animal, and environmental factors, emphasizing the need for an interdisciplinary approach to brucellosis monitoring, prevention, and control. Vector vaccines based on influenza virus (Flu-BA), developed in Kazakhstan, have shown high promise, combining immunogenicity, protective efficacy, and a favorable safety profile. Promising directions remain mRNA vaccines, nanoparticles, CRISPR/Cas9 technologies, and mucosal vaccines.

28 November 2025 in Plants
Verified
Journal Article
Open access
PDF file
ASAigerim Sagymbayeva
Aigerim Sagymbayeva
NTNasya TOMLEKOVA
Nasya TOMLEKOVA
GSGalymzhan Saparov
Galymzhan Saparov
YAYergali Abduraimov
Yergali Abduraimov
AKAslan Kerimbaev
Aslan Kerimbaev
BABakytzhan Anapiyayev
Bakytzhan Anapiyayev
Soil contamination with heavy metals is a persistent challenge in the arid regions of Kazakhstan. This study evaluates the phytoremediation potential of sweet sorghum (Sorghum bicolor L.), a drought-tolerant crop with a well-developed root system, using a combination of in vitro and analytical approaches. In vitro culture of somatic cells revealed clear genotype-dependent differences in callus induction and morphogenesis, with Hybrid-2 and SAB-3 exhibiting the highest regenerative capacity and thus the greatest suitability for further biotechnological improvement and stress-tolerance selection. Analysis of metal distribution, based on atomic absorption spectroscopy (AAS), demonstrated that S. bicolor predominantly retained Pb, Cd, and Co in the root system. Cobalt accumulated to 12.7 ± 1.32 mg/kg under 1 MAC and 16.87 ± 2.78 mg/kg under 2 MAC, accounting for more than half of the metal absorbed by plants. Cadmium showed a similar root-dominant pattern, whereas lead exhibited the lowest mobility and remained almost entirely sequestered in roots, with translocation factors consistently below unity (TF < 1). Overall, these findings confirm the suitability of sweet sorghum as an environmentally sustainable species for the phytostabilization of Pb-, Cd-, and Co-contaminated soils in arid environments and highlight the value of genotype pre-selection under stress conditions for optimizing phytoremediation performance.

23 April 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
Nurlan AkmyrzayevNurlan Akmyrzayev
Nurlan Akmyrzayev
SRSholpan Ryskeldinova
Sholpan Ryskeldinova
AMAigerim Mailybayeva
Aigerim Mailybayeva
EKErken Kozhamkulov
Erken Kozhamkulov
ASAigerim Sagymbayeva
Aigerim Sagymbayeva
NANurika Narynbekovna Assanzhanova
Nurika Narynbekovna Assanzhanova
Background/Objectives: Despite the availability of Newcastle disease (ND) vaccines, outbreaks have continued to occur for more than six decades, with significant economic consequences for the global poultry industry. The variability of the Newcastle disease virus requires constant monitoring, detection of new cases, and studies of the origin of the pathogen. The aim of this study was to develop an inactivated ND vaccine using a topical strain with different adjuvants and to compare them for stability, harmlessness, immunogenicity, and efficacy. Methods: A phylogenetic study of the F-gene of the ND strain isolated in Kazakhstan was conducted. The strain, which was selected to create a vaccine for the prevention of the disease, was revealed to belong to genotype VII class II and uploaded to GenBank (NCBI). Two different adjuvants, Montanide ISA 70 VG and Montanide ISA 78 VG, were used to create the vaccine. Birds were vaccinated intramuscularly. Results: Evaluations of antibody titers in the vaccinated groups during the experiment showed that the vaccines induced adequate levels of antibodies to provide protection against the virulent virus. High antibody titers were observed in the hemagglutination inhibition assay (HAI) in the vaccinated groups as early as 14 days post-vaccination in 100% of birds. The average antibody titer in both vaccinated groups exceeded 7 log2, sufficient to prevent clinical signs. None of the vaccinated birds exhibited clinical signs following control infection, whereas unvaccinated birds developed clinical manifestations within three days post-infection, leading to 100% mortality. Conclusions: The vaccine developed using the epizootic topical strain is stable, harmless, immunogenic, and effective when challenged with a virulent ND virus strain at a dose of 105 EID50/mL.

22 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ASAigerim Sagymbayeva
Aigerim Sagymbayeva
NTNasya TOMLEKOVA
Nasya TOMLEKOVA
GSGalymzhan Saparov
Galymzhan Saparov
EAE. O. Abduraimov
E. O. Abduraimov
AKAslan Kerimbaev
Aslan Kerimbaev
BABakytzhan B. Anapiyayev
Bakytzhan B. Anapiyayev
In recent years, soil contamination with heavy metals—such as plumbum, cadmium, and cobalt—has become an increasingly pressing environmental issue due to the rapid expansion of industry, transportation, and urbanization. These elements are non-biodegradable, gradually accumulate along trophic chains, and can ultimately exert serious adverse effects on human health. In this study, we focused on sweet sorghum (Sorghum bicolor L.) as a promising candidate for phytoremediation of heavy metal–contaminated soils. Both field and laboratory approaches were employed: in vitro culture of somatic cells was used to select stress-tolerant and high-yielding genotypes, while atomic absorption spectroscopy (AAS) was applied to quantify heavy metal concentrations in soil and plant tissues. Experimental results demonstrated that callus induction frequency was strongly genotype-dependent. The highest callus formation rates were observed in Hybrid-2 (69.11%), SAB-3 (43.83%), SABB-1 (42.31%), and SAB-10 (40.32%). Among these, Hybrid-2 (27.94%) and SAB-3 (23.28%) also exhibited the highest frequencies of morphogenic callus formation, confirming their suitability for subsequent micropropagation and cell-based selection. Particular attention was paid to the distribution of toxicants among plant organs. The rate and direction of metal translocation from roots to shoots were found to critically influence the efficiency of subsequent metal removal, as stems constitute the major component of easily harvestable biomass. Nevertheless, a substantial proportion of heavy metals remained sequestered in the roots: cobalt concentrations reached 12.7 ± 1.32 mg/kg at 1 MPC (Maximum Permissible Concentration) and 16.87 ± 2.78 mg/kg at 2 MPC, accounting for more than 50% of the total accumulated amount. Similar trends were observed for cadmium (~49%) and plumbum (up to 53%). Thus, our findings underscore the pivotal role of genotype in in vitro callus formation and morphogenesis, and further highlight the potential of sweet sorghum as an effective phytoremediation agent for reclaiming heavy metal–contaminated lands, particularly in arid regions.

19 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Nurlan AkmyrzayevNurlan Akmyrzayev
Nurlan Akmyrzayev
SRSholpan Ryskeldinova
Sholpan Ryskeldinova
AMAigerim Mailybayeva
Aigerim Mailybayeva
EKErken Kozhamkulov
Erken Kozhamkulov
ASAigerim Sagymbayeva
Aigerim Sagymbayeva
NANurika Narynbekovna Assanzhanova
Nurika Narynbekovna Assanzhanova
Despite the availability of Newcastle disease (ND)vaccines, outbreaks have continued to occur for more than six decades, with huge economic consequences for the global poultry industry. The variability of the Newcastle disease virus requires constant monitoring, detection of new cases and study of the origin of the pathogen. The aim of the study was to develop an inactivated ND vaccine using a topical strain with different adjuvants and to compare them for stability, harmlessness, immunogenicity and efficacy. As a result of the phylogenetic study of the F-gene of the ND strain isolated in Kazakhstan, selected to create a vaccine for the prevention of this disease, it was revealed that this pathogen belongs to the genotype VII class II and was uploaded to GenBank (NCBI). Two different adjuvants were used to create the vaccine – Montanide ISA 70 VG and Montanide ISA 78 VG. The birds were vaccinated intramuscularly. Evaluation of antibody titers in the vaccinated groups during the experiment shows that the vaccines were able to induce adequate levels of antibodies to provide protection against the virulent virus. Vaccination provided high antibody titers in the HAI in the vaccinated groups as early as 14 days after vaccination in 100% of birds. When studying the effectiveness of vaccines, the average antibody titer in both vaccinated groups was above 7 log2, which is more than enough to protect birds from clinical signs. None of the vaccinated birds showed clinical signs after control infection. In groups of unvaccinated birds, clinical manifestations were observed as early as 3 days after infection with increasing severity, and eventually they all died (100% mortality). The vaccine from the epizootic topical strain developed by us is stable, harmless, immunogenic and effective when infected with a virulent strain of the ND virus at a dose of 100,000 EID50/cm3.

17 July 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
NANurika Narynbekovna Assanzhanova
Nurika Narynbekovna Assanzhanova
ASAigerim Sagymbayeva
Aigerim Sagymbayeva
GSGaukhar Shynybekova
Gaukhar Shynybekova
KSKamshat Shorayeva
Kamshat Shorayeva
SRSholpan Ryskeldinova
Sholpan Ryskeldinova
Nurlan AkmyrzayevNurlan Akmyrzayev
Nurlan Akmyrzayev
Background: Brucellosis remains a significant zoonotic infection affecting approximately 500,000 people worldwide annually, with no licensed human vaccine available. Recombinant influenza virus vectors expressing Brucella spp. antigens represent a promising vaccine platform. However, transitioning from laboratory constructs to clinical candidates requires validation of scalable purification methods compliant with Good Manufacturing Practice (GMP) standards. This study aimed to develop and optimize a pilot-scale purification protocol for these vectors. Methods: Recombinant influenza A viruses (H5N1) expressing Brucella spp. antigens (Omp16, Omp19, L7/L12, Cu-Zn SOD) were propagated in MDCK cell culture. The optimized purification process included: (1) clarification; (2) ultrafiltration/diafiltration (100 kDa MWCO); (3) two-step chromatography (anion-exchange Q-Sepharose® Fast Flow and multimodal Capto™ Core 700); and (4) sterile filtration. Process validation was performed across three independent pilot-scale batches (20 L each). Results: The purification process demonstrated high reproducibility for all constructs. Final preparations met established quality criteria: infectious titer ≥ 5.2 log10 TCID50/mL, hemagglutination activity 7.33 ± 0.58–8.33 ± 0.58 log2, total protein content 157–305 μg/mL, residual host cell DNA < 10 ng/dose, and bacterial endotoxin levels ≤ 0.15 IU/mL. The overall recovery of infectious virus was 20–24%, an optimal value for multi-stage bioprocessing. Preservation of the target genetic insert was confirmed in all final preparations by PCR and sequencing. Conclusions: The developed integrated purification protocol yields vectors with high purification efficiency, preserving biological activity and meeting regulatory quality requirements for residual host cell DNA and endotoxins. The technological platform demonstrated versatility, robustness (inter-batch coefficient of variation for yield did not exceed 10–12%), and scalability, establishing a foundation for preclinical and clinical studies of candidate brucellosis vaccines.